Login
$WVE
$2.87 +$0.00 (0.0%) After hours

$WVE SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
27 Oct 2026 SCHEDULE 13G
27 Oct 2026 SCHEDULE 13G/A
27 Oct 2026 10-Q
27 Oct 2026 8-K: Results of Operations and Financial Condition

Planning underway for registrational trial of WVE-006 (RNA editing) in AATD, with an interim analysis for potential accelerated approval based on AATD biomarkers

14 Oct 2026 ARS
14 Oct 2026 Proxy statement: annual meeting on November 12, 2026

CEO pay $12.3M, up 187% · say-on-pay vote

07 Oct 2026 Form 4: Ra Capital MANAGEMENT, L.p., Director and 3 others

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (Right to Buy)

07 Oct 2026 Form 4: Verdine Gregory L., Director

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (right to buy)

07 Oct 2026 Form 4: Tan Aik Na, Director

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (right to buy)

07 Oct 2026 Form 4: Takanashi Ken, Director

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (right to buy)

07 Oct 2026 Form 4: Corrigan Mark, Director

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (right to buy)

07 Oct 2026 Form 4: Rawcliffe Adrian, Director

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (right to buy)

07 Oct 2026 Form 4: Wagner Heidi L, Director

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (right to buy)

07 Oct 2026 Form 4: Henry Christian O, Director

Received 10,700 shares as a grant or award · Granted 64,000 Stock Option (right to buy)

14 Aug 2026 EFFECT
13 Aug 2026 Form 4: Wagner Heidi L, Director

Received 7,000 shares by exercise or conversion ($41.8K) · Sold 7,000 shares ($42.1K)

13 Aug 2026 Form 4: Rawcliffe Adrian, Director

Sold 12,700 shares ($67.2K)

13 Aug 2026 Form 4: Takanashi Ken, Director

Sold 3,864 shares ($23.2K)

13 Aug 2026 Form 4: Tan Aik Na, Director

Sold 432 shares ($2.6K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support